Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilot trial

BACKGROUND: Nab-paclitaxel is produced by the combination of paclitaxel particles with human serum albumin. Encouraging efficacy has been observed with nab-paclitaxel-based chemotherapy in a variety of solid tumors. The aim of the study reported here was to evaluate the efficacy and safety of weekly...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Daquan, Zhang, Wencheng, Qian, Dong, Guan, Yong, Chen, Xi, Zhang, Hualei, Wang, Jun, Pang, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167982/
https://www.ncbi.nlm.nih.gov/pubmed/30319273
http://dx.doi.org/10.2147/OTT.S168275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167982/
https://www.ncbi.nlm.nih.gov/pubmed/30319273
http://dx.doi.org/10.2147/OTT.S168275

Ejemplares similares